DR. RAZA BOKHARI, FORMER EXECUTIVE CHAIRMAN AND CEO OF FSD PHARMA, FILES TWO ADDITIONAL CLAIMS AGAINST THE COMPANY SEEKING RELIEF AND MONETARY DAMAGES EXCEEDING $30.2 MILLION
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Details
News Market Reaction – HUGE
The recorded move for HUGE in the trading session of this news was +6.02%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The two matters filed with the
Dr. Bokhari already has an existing Application before the
"Blake's makes a claim on their website that they are 'adept at selecting the right arbitrators'", said Dr. Bokhari.
In addition to these disputes outlined above, FSD Pharma was recently sued for
About Dr. Raza Bokhari
A recipient of Philadelphia Business Journal's "40 under 40" award, Dr. Raza Bokhari, has developed outstanding expertise in aggregating and accelerating life sciences, healthcare services and Pharmaceutical R&D companies.
Dr. Bokhari is the managing partner of RBx Capital, LP, and is nominated as the Executive Chairman & CEO of Medicus Pharma, Ltd, a biotech company developing innovative and non-invasive therapies to treat cancerous melanomas. The company is expected to begin trading on Toronto Stock Exchange (TSXV).
For more information on Dr. Bokhari, including the complete story of his tenure at FSD Pharma, please visit razabokhari.com
For Further Information:
RBx Capital, LP: Carolyn Bonner, Principal (610)636-0184 cbonner@rbxcapital.net
SOURCE RBx Capital LP